
Identität
Azetidon
Nicht angegeben · C13H25NO4Si
01Identität
| Lazychem ID | LC-79413 |
|---|---|
| CAS RN | Nicht angegeben |
| PubChem CID | 10935078 |
| Molecular formula | C13H25NO4Si |
| Molecular weight | 287.43 g/mol |
| IUPAC name | [(2R,3R)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl] acetate |
| InChIKey | GWHDKFODLYVMQG-UBHAPETDSA-N |
02Struktur und Stereochemie

The parsed structure contains 1 ring, includes aliphatic carbon, has 3 defined stereocentres. These statements are calculated from the published structure string.
| Defined stereocentres | 3 |
|---|---|
| Ring count | 1 |
| Secondary amines | 0 |
| Tertiary amines | 0 |
| SMILES | C[C@H]([C@@H]1[C@H](NC1=O)OC(=O)C)O[Si](C)(C)C(C)(C)C |
|---|---|
| InChI | Nicht angegeben |
03Stereochemistry
The published structure contains 3 defined and 0 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.
Published same-connectivity configurations
6 recordsThese records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

![Two-dimensional chemical structure of (3R,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy) ethyl]azetidin-2-one](/structures/pubchem/13073892-300.png)
(3R,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy) ethyl]azetidin-2-one
CAS not listed
GWHDKFODLYVMQG-PTOFAABTSA-N
3 defined, 0 unassigned centres
![Two-dimensional chemical structure of [(2S,3R)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl] acetate](/structures/pubchem/10968170-300.png)
[(2S,3R)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl] acetate
CAS not listed
GWHDKFODLYVMQG-QRTLGDNMSA-N
3 defined, 0 unassigned centres
![Two-dimensional chemical structure of [(2S,3R)-3-[(1S)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl] acetate](/structures/pubchem/13073897-300.png)
[(2S,3R)-3-[(1S)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl] acetate
CAS not listed
GWHDKFODLYVMQG-PEXQALLHSA-N
3 defined, 0 unassigned centres
![Two-dimensional chemical structure of [(2S,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl] acetate](/structures/pubchem/13073888-300.png)
[(2S,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl] acetate
CAS not listed
GWHDKFODLYVMQG-UISBYWKRSA-N
3 defined, 0 unassigned centres
![Two-dimensional chemical structure of [(2S,3S)-3-[(1S)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl] acetate](/structures/pubchem/53860740-300.png)
[(2S,3S)-3-[(1S)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl] acetate
CAS not listed
GWHDKFODLYVMQG-XRNSZHNASA-N
3 defined, 0 unassigned centres
Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.
04Status in Indien
Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.
05Namen und Beziehungen
API und Ausgangsarzneistoff
Nicht angegeben
Namen und Beziehungen
06Quellen
- S01PubChem CID 10935078
Structure and machine-readable chemical identifiers.
